Cargando…

What can we learn from Israel’s rapid roll out of COVID 19 vaccination?

Israel has led the world in rolling out its COVID-19 vaccination program. This experience provides lessons that others can learn from. It is, however, necessary to consider some national specificities, including the small size of the country, its young population, and the political imperative to dri...

Descripción completa

Detalles Bibliográficos
Autores principales: McKee, Martin, Rajan, Selina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835666/
https://www.ncbi.nlm.nih.gov/pubmed/33499901
http://dx.doi.org/10.1186/s13584-021-00441-5
_version_ 1783642579588349952
author McKee, Martin
Rajan, Selina
author_facet McKee, Martin
Rajan, Selina
author_sort McKee, Martin
collection PubMed
description Israel has led the world in rolling out its COVID-19 vaccination program. This experience provides lessons that others can learn from. It is, however, necessary to consider some national specificities, including the small size of the country, its young population, and the political imperative to drive this program forward. Israel also has a number of other advantages, including a strong public health infrastructure. The lessons that can be learnt include the importance of coordinating delivery mechanisms with the inevitable prioritisation of groups within the population, timely deployment of a skilled cadre of health workers, a recognition that not everyone in the population shares in the benefits of digital connectedness, the need to reach out to disadvantaged groups, based on an understanding of the barriers that they face, and the importance of placing COVID-19 vaccination within a comprehensive response to the pandemic.
format Online
Article
Text
id pubmed-7835666
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78356662021-01-26 What can we learn from Israel’s rapid roll out of COVID 19 vaccination? McKee, Martin Rajan, Selina Isr J Health Policy Res Commentary Israel has led the world in rolling out its COVID-19 vaccination program. This experience provides lessons that others can learn from. It is, however, necessary to consider some national specificities, including the small size of the country, its young population, and the political imperative to drive this program forward. Israel also has a number of other advantages, including a strong public health infrastructure. The lessons that can be learnt include the importance of coordinating delivery mechanisms with the inevitable prioritisation of groups within the population, timely deployment of a skilled cadre of health workers, a recognition that not everyone in the population shares in the benefits of digital connectedness, the need to reach out to disadvantaged groups, based on an understanding of the barriers that they face, and the importance of placing COVID-19 vaccination within a comprehensive response to the pandemic. BioMed Central 2021-01-26 /pmc/articles/PMC7835666/ /pubmed/33499901 http://dx.doi.org/10.1186/s13584-021-00441-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
McKee, Martin
Rajan, Selina
What can we learn from Israel’s rapid roll out of COVID 19 vaccination?
title What can we learn from Israel’s rapid roll out of COVID 19 vaccination?
title_full What can we learn from Israel’s rapid roll out of COVID 19 vaccination?
title_fullStr What can we learn from Israel’s rapid roll out of COVID 19 vaccination?
title_full_unstemmed What can we learn from Israel’s rapid roll out of COVID 19 vaccination?
title_short What can we learn from Israel’s rapid roll out of COVID 19 vaccination?
title_sort what can we learn from israel’s rapid roll out of covid 19 vaccination?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835666/
https://www.ncbi.nlm.nih.gov/pubmed/33499901
http://dx.doi.org/10.1186/s13584-021-00441-5
work_keys_str_mv AT mckeemartin whatcanwelearnfromisraelsrapidrolloutofcovid19vaccination
AT rajanselina whatcanwelearnfromisraelsrapidrolloutofcovid19vaccination